GLP-1s

By Lily Mae LazarusJuly 1, 2026

RetailRich consumers taking GLP-1s are rebuying their wardrobes and eating smaller, fancier dishes—it’s a factor saving the luxury sector right now
By Eleanor PringleJune 25, 2026

HealthHow ‘Ozempic face’ is pushing Gen X, already the biggest Botox and filler consumers, to the facelift table a decade early
By Mia OsmonbekovJune 24, 2026

North AmericaUPS is shelling out nearly $50 million on temperature-controlled facilities to meet the booming demand for GLP-1 deliveries
By Sasha RogelbergJune 23, 2026

By Tenzin SeldonJune 21, 2026

By Lily Mae LazarusApril 18, 2026

By Dee-Ann Durbin and The Associated PressMarch 12, 2026

By Ziyad Al-Aly and The ConversationMarch 6, 2026

BankingMeat snacks have emerged as the clear winner in America’s seismic GLP-1 consumption shift, while popcorn is down
By Nick LichtenbergFebruary 10, 2026

By Tara ComonteFebruary 9, 2026

C-SuitePfizer CEO on how he struck a deal with President Trump in 10 days to lower American drug costs
By Fortune EditorsJanuary 27, 2026

HealthGLP-1s could end up being ‘the first true longevity drug’ as the world battles a rising obesity crisis
By Angelica AngNovember 21, 2025

C-SuiteRay Dalio is backing a $1 billion blueberry unicorn that sells berries nearly the size of golf balls
By Eva RoytburgNovember 4, 2025
Most Popular




